To extend this analysis to neuroprotection and cerebral ischemia treatment, overexpression or inhibition of miR-21 in vivo was performed to detect the effect of miR-21 on p53/Bcl-2/Bax signaling and cerebral ischemic damage. The gene discussed is BCL2; the disease is Cerebral ischemia.